Related Experiment Video

Updated: Jun 9, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

Innovative strategies in genitourinary cancer: the role of oncolytic viruses

Jie Zhang1,2, Kepu Liu2, Zheng Zhu2

  • 1College of Life Sciences, Northwest University, Xi'an, Shaanxi, China.

Frontiers in Oncology
|October 28, 2024
PubMed

Insights

Oncolytic viruses offer a promising alternative for treating urinary cancers like renal, bladder, and prostate cancers, especially when traditional therapies fail. These viruses selectively destroy cancer cells and stimulate anti-tumor immunity.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Urinary tumors present significant challenges due to high prevalence and recurrence.
  • Many patients exhibit poor response to conventional treatments, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To review recent advancements and future directions in the application of oncolytic viruses for urinary cancers.
  • To explore the potential of various oncolytic viruses in treating renal, bladder, and prostate cancers.

Main Methods:

  • Literature review of current research on oncolytic virotherapy for urinary malignancies.
  • Discussion of specific oncolytic viruses such as cowpox virus, adenovirus, measles virus, coxsackievirus, and reovirus.
  • Analysis of practical implications and future prospects of oncolytic virus therapy.

Main Results:

  • Oncolytic viruses demonstrate potential as targeted cancer therapeutics.
  • These viruses selectively infect and lyse cancer cells, sparing healthy tissues.
  • Oncolytic virus activity can elicit robust anti-tumor immune responses.

Conclusions:

  • Oncolytic virus therapy is a promising approach for managing urinary cancers.
  • Further research and refinement are needed to optimize the use of different oncolytic viruses.
  • This therapeutic modality holds potential for improving patient outcomes in renal, bladder, and prostate cancers.
Keywords:
bladder canceroncolytic virusprostate cancerrenal cancertherapytumor

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.0K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.5K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K